U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06253078) titled 'Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients' on Jan. 29.
Brief Summary: ciprofol is a recently introduced novel sedative drug. In comparison to the traditional propofol, ciprofol exhibits a higher affinity for GABA A receptors, approximately 4-5 times that of propofol, and possesses fewer side effects, particularly notable in respiratory depression and injection pain. In the context of general anesthesia induction, recent research has confirmed a 100% success rate in the induction of general anesthesia for elderly patients (65-80 years old) undergoing non-cardiac surgery with a dosage range of 0.2mg/kg-0.4mg...